Literature DB >> 1409187

Autoimmunity and glomerulonephritis.

R Saxena1, C Johansson, P Bygren, J Wieslander.   

Abstract

Autoimmunity is now unequivocally regarded as the predominant pathogenic process underlying most forms of primary and secondary glomerulonephritis in humans. Most of the investigations so far have been focused upon humoral mechanisms. Consequently, the role of cell-mediated immunity in nephritis is still incompletely understood. Nonetheless, as a result of contemporary studies, a number of previously unidentified auto-antibodies in association with glomerulonephritis have been discovered. However, apart from anti-NC1 antibodies in the classical Goodpasture syndrome, the exact role of these auto-antibodies in the pathogenesis of glomerulonephritis yet remains undefined. This fact, however, does not undermine the relevance of exploring these auto-antibodies. They have been of immense help in sub-classifying glomerulonephritis previously thought homogeneous (Figure 3). Besides, analysis of auto-antibodies has assisted tremendously in the early diagnosis of rapidly progressive glomerulonephritis. This, in turn, has aided in early commencement of therapy thus contributing to regression in morbidity and mortality resulting from these disorders. Moreover, investigation of these auto-antibodies is of enormous value for future studies aimed at understanding the pathogenic mechanisms involved in glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409187      PMCID: PMC2399267          DOI: 10.1136/pgmj.68.798.242

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  64 in total

1.  Delineation of a standard procedure for indirect immunofluorescence detection of ANCA.

Authors:  A Wiik
Journal:  APMIS Suppl       Date:  1989

Review 2.  Pathogenesis of anti-basement membrane glomerulopathy and immune-complex glomerulonephritis: dichotomy dissolved.

Authors:  J A Bruijn; P J Hoedemaeker; G J Fleuren
Journal:  Lab Invest       Date:  1989-11       Impact factor: 5.662

3.  Entactin: a possible auto-antigen in the pathogenesis of non-Goodpasture anti-GBM nephritis.

Authors:  R Saxena; P Bygren; R Butkowski; J Wieslander
Journal:  Kidney Int       Date:  1990-08       Impact factor: 10.612

4.  Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis.

Authors:  J A Bruijn; E H van Leer; H J Baelde; W E Corver; P C Hogendoorn; G J Fleuren
Journal:  Lab Invest       Date:  1990-09       Impact factor: 5.662

5.  Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells.

Authors:  D Bories; M C Raynal; D H Solomon; Z Darzynkiewicz; Y E Cayre
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

6.  Glomerulonephritis mediated by antibody to glomerular basement membrane. Immunological, clinical, and histopathological characteristics.

Authors:  J J McPhaul; J D Mullins
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

7.  Serum IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schönlein purpura: diagnostic value and pathogenic implications. The Glomerular Disease Collaborative Network.

Authors:  J C Jennette; J Wieslander; R Tuttle; R J Falk
Journal:  Am J Kidney Dis       Date:  1991-10       Impact factor: 8.860

8.  Circulating autoantibodies in patients with extracapillary glomerulonephritis.

Authors:  R Saxena; P Bygren; N Rasmussen; J Wieslander
Journal:  Nephrol Dial Transplant       Date:  1991       Impact factor: 5.992

9.  Evidence of an autologous immune complex pathogenic mechanism in acute poststreptococcal glomerulonephritis.

Authors:  R M McIntosh; R García; L Rubio; D Rabideau; J E Allen; R I Carr; B Rodríguez-Iturbe
Journal:  Kidney Int       Date:  1978-11       Impact factor: 10.612

10.  Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease.

Authors:  J A Bruijn; P C Hogendoorn; W E Corver; L J van den Broek; P J Hoedemaeker; G J Fleuren
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.